HOME >> BIOLOGY >> NEWS
American Institute of Chemists names Ralph Hirschmann AIC Gold Medalist

PHILADELPHIA 11 April 2003 The American Institute of Chemists (AIC) and the Chemical Heritage Foundation (CHF) will present the 2003 AIC Gold Medal to Ralph F. Hirschmann. The award ceremony will be part of Heritage Day festivities at CHF in Philadelphia, Pennsylvania, on Thursday, 12 June 2003.

It is fitting that the first AIC Gold Medal awarded jointly by CHF and the AIC be presented to a pharmaceutical researcher with the talent, skills, and insight of Ralph Hirschmann, said Arnold Thackray, president of CHF. At Merck, he was head of the effort that developed effective drugs to treat hypertension, congestive heart failure, severe infection, river blindness in developing countries, and many other illnesses. His remarkable accomplishments as a researcher include the synthesis of the enzyme ribonuclease in solution, the first example of protein synthesis.

The presentation of the AIC Gold Medal will be part of a day devoted to celebrating the achievement and promise of the chemical and molecular sciences. Heritage Day begins with the awarding of the Othmer Gold Medal to John D. Baldeschwieler and George S. Hammond. In the late afternoon, Hirschmann will receive the AIC Gold Medal. Following a reception, the Winthrop-Sears Medal of The Chemists Club will be presented at a dinner at nearby Carpenters Hall.

Ralph F. Hirschmann
Ralph F. Hirschmann is Makineni Professor of Bioorganic Chemistry at the University of Pennsylvania. He joined the Penn faculty in 1987 after retiring as Mercks senior vice president of basic research. He was affiliated with Merck for 37 years, during which time he fostered interdisciplinary research as well as collaborations between academia and industry, practices he has continued at Penn.

Several widely used medications stem from Hirschmanns tenure at Merck, including the parasite-fighting Ivomec. And, in a major theoretical contribution to organic chemistry, he was the first to discover that chem
'"/>

Contact: Neil Gussman
neilg@chemheritage.org
717-314-2494
Chemical Heritage Foundation
16-Apr-2003


Page: 1 2

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:
(Date:5/21/2015)... -- The Sync Project™ , a global collaboration ... announced a collaborative partnership with Berklee,s Institute for ... collaboration on original research, joint course development and an ... The Sync Project and BerkleeICE are exploring the launch ... 2015-2016 academic year.  The course will ...
(Date:5/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... owned subsidiary, 3D-ID LLC, a company engaged in biometric ... the biometrics technology portion of the recently awarded TIES ... Department of the Army. 3D-ID LLC has ... government, law enforcement and security agencies. ...
(Date:5/19/2015)... 19, 2015  Technology is rapidly advancing, outpacing enterprises, ... the cloud. Passwords and their management are soon to ... standards-based specifications such as those developed by the FIDO ... passwords presents for BYOD, COPE, IoT, and mobile payments, ... protocol. In response to the call ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
(Date:5/21/2015)... Prussia, PA (PRWEB) May 21, 2015 ... O’Neill has joined the firm as senior statistician and ... 30 years of experience in the management and analysis ... biologics, pharmaceutical and chemical industries. , “We’re delighted to ... longstanding capabilities in data analytics,” said Dr. Philippe Cini, ...
(Date:5/20/2015)... Pa. , May 20, 2015  Select ... that the Federal Trade Commission granted early termination ... Antitrust Improvements Act of 1976, as amended, applicable ... MJ Acquisition Corporation, a joint venture that Select ... L.P. As previously announced, MJ Acquisition ...
(Date:5/20/2015)... 2015  Haemonetics Corporation (NYSE: HAE ) announced ... will present at The Jefferies 2015 Global Healthcare Conference ... 1 st , 2015 at 8:30am Eastern time.  ... live via webcast at: http://wsw.com/webcast/jeff88/hae ... ) is a global healthcare company dedicated to providing ...
(Date:5/20/2015)... MA (PRWEB) May 20, 2015 ... transporter assay services for Drug-Drug Interactions (DDI), Metabolism ... Pharma, a world leader in assessing impact of ... Systems Pharmacology supported by biosimulation, announced today that ... agreement allows both companies to expand their product ...
Breaking Biology Technology:Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3
Cached News: